Stockreport

Share this Story: AbbVie's Humira gets a U.S. rival, but costs could stay high [Financial Post (Toronto, Ontario, Canada)]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF U.S. patients will finally get access to cheaper versions of AbbVie Inc's blockbuster arthritis drug Humira this year, but the cost savings are expected to be limited. [Read more]